Skip to main content

Table 1 Univariate analysis of baseline characteristics and clinical outcome

From: Outcomes and risk factors for functional prognosis at 3 months after intravenous thrombolysis with r-tPA in patients with acute ischemic stroke: a retrospective cohort study

Characteristics

All patients

(n = 3805)

Good outcome

(n = 3176)

Poor outcome

(n = 629)

P value

Age (median [IQR])

59 (51, 69)

58 (50, 68)

66 (55, 76)

< 0.001

Sex (male), N (%)

2676 (70.3)

2276 (71.7)

400 (63.6)

< 0.001

BMI (median [IQR])

24.12 (21.64, 26.25)

24.22 (21.86, 26.28)

23.44 (20.67, 25.97)

0.011

Baseline NIHSS score, median (IQR)

4 (2, 8)

4 (2, 7)

10 (5, 14.25)

< 0.001

ODT, min (median [IQR])

88 (50, 145)

88 (50, 145)

88 (48, 148)

0.915

DNT, min (median [IQR])

35 (26, 49)

35 (26, 48)

35 (27, 50)

0.364

ONT, min (median [IQR])

133 (88, 193)

132 (88, 192)

138 (87, 195)

0.569

Medical history, n (%)

    

 Smoking

1301 (34.2)

1110 (34.9)

191 (30.5)

0.027

 Alcohol drinking

928 (24.4)

786 (24.7)

142 (22.6)

0.246

 Hypertension

1130 (29.7)

957 (30.1)

173 (27.5)

0.188

 Diabetes

356 (9.4)

268 (8.4)

88 (14.0)

< 0.001

 Previous stroke

622 (16.3)

487 (15.3)

135 (21.5)

< 0.001

Blood pressure, median (IQR)

    

 Systolic blood pressure, mmHg

148 (132, 163)

147 (132, 162)

150 (134, 165)

0.106

 Diastolic blood pressure, mmHg

88 (79, 98)

88 (80, 98)

87 (78, 97)

0.019

Laboratory examination, median (IQR)

    

 Serum glucose, mmol/L

5.90 (5.05, 7.42)

5.80 (5.00, 7.11)

6.71 (5.50, 8.95)

< 0.001

 LDL-C, mmol/L

2.90 (2.28, 3.54)

2.92 (2.29, 3.53)

2.82 (2.23, 3.56)

0.163

 Neutrophil, 109/L

4.80 (3.69, 6.60)

4.71 (3.63, 6.47)

5.32 (4.03, 7.50)

< 0.001

 Lymphocyte, 109/L

2.00 (1.45, 2.72)

2.05 (1.50, 2.75)

1.82 (1.26, 2.57)

< 0.001

 hs-CRP, mg/L

1.68 (0.55, 4.60)

1.51 (0.50, 4.11)

2.50 (0.84, 7.60)

< 0.001

 Fibrinogen, mg/dL

2.99 (2.52, 3.57)

2.95 (2.49, 3.52)

3.13 (2.66, 3.84)

< 0.001

 D-dimer, mg/L

0.44 (0.22, 1.38)

0.40 (0.22, 1.17)

0.90 (0.30, 2.61)

< 0.001

 HbA1c, %

5.90 (5.60, 6.50)

5.90 (5.50, 6.40)

6.10 (5.60, 7.20)

< 0.001

 ALT, U/L

20 (15, 29)

21 (15, 29)

19 (14, 25)

< 0.001

 Cystatin C, mg/L

1.00 (0.81, 1.34)

1.00 (0.81, 1.34)

1.00 (0.82, 1.33)

0.849

 Serum uric acid, µmol/L

348.63 (285.90, 426.00)

351.00 (287.90, 429.25)

337.00 (271.10, 408.70)

0.001

 Serum creatinine, µmol/L

74.20 (62.00, 88.50)

74.10 (62.00, 88.00)

74.90 (61.40, 92.00)

0.411

 BUN, mmol/L

5.41 (4.34, 6.71)

5.39 (4.31, 6.61)

5.60 (4.46, 7.32)

0.001

 Hcy, µmol/L

 Hcy, µmol/L

11.90 (9.5, 15.40)

11.80 (9.40, 15.30)

12.16 (9.90, 16.00)

0.074

  1. BMI: body mass index; ODT: onset to door time; DNT: door-to-needle time; ONT: onset-to-needle time; LDL-C: low-density lipoprotein cholesterol; hs-CRP: high-sensitivity C-reactive protein; HbA1c: hemoglobinA1c; ALT: alanine aminotransferase; BUN: blood urea nitrogen; Hcy: homocysteine